nodes	percent_of_prediction	percent_of_DWPC	metapath
Beclomethasone—CYP3A5—Rosuvastatin—atherosclerosis	0.229	0.267	CbGbCtD
Beclomethasone—CYP3A5—Simvastatin—atherosclerosis	0.213	0.248	CbGbCtD
Beclomethasone—CYP3A5—Lovastatin—atherosclerosis	0.208	0.243	CbGbCtD
Beclomethasone—CYP3A5—Pravastatin—atherosclerosis	0.208	0.243	CbGbCtD
Beclomethasone—Glaucoma—Niacin—atherosclerosis	0.00485	0.0418	CcSEcCtD
Beclomethasone—Cataract—Lovastatin—atherosclerosis	0.00447	0.0385	CcSEcCtD
Beclomethasone—Cataract—Simvastatin—atherosclerosis	0.00418	0.036	CcSEcCtD
Beclomethasone—Cataract—Pravastatin—atherosclerosis	0.00378	0.0326	CcSEcCtD
Beclomethasone—CYP3A5—Irinotecan Pathway—NPC1—atherosclerosis	0.00288	0.146	CbGpPWpGaD
Beclomethasone—Nasopharyngitis—Ezetimibe—atherosclerosis	0.00271	0.0233	CcSEcCtD
Beclomethasone—Sinusitis—Rosuvastatin—atherosclerosis	0.00264	0.0227	CcSEcCtD
Beclomethasone—Betamethasone—PLA2G1B—atherosclerosis	0.00262	0.454	CrCbGaD
Beclomethasone—Pharyngitis—Rosuvastatin—atherosclerosis	0.0025	0.0216	CcSEcCtD
Beclomethasone—Nasopharyngitis—Pravastatin—atherosclerosis	0.00234	0.0201	CcSEcCtD
Beclomethasone—Sinusitis—Lovastatin—atherosclerosis	0.00223	0.0192	CcSEcCtD
Beclomethasone—Sinusitis—Ezetimibe—atherosclerosis	0.00219	0.0189	CcSEcCtD
Beclomethasone—Sinusitis—Simvastatin—atherosclerosis	0.00209	0.018	CcSEcCtD
Beclomethasone—Pharyngitis—Ezetimibe—atherosclerosis	0.00208	0.0179	CcSEcCtD
Beclomethasone—Angioedema—Rosuvastatin—atherosclerosis	0.00201	0.0173	CcSEcCtD
Beclomethasone—Cough—Rosuvastatin—atherosclerosis	0.00192	0.0165	CcSEcCtD
Beclomethasone—Sinusitis—Pravastatin—atherosclerosis	0.00189	0.0163	CcSEcCtD
Beclomethasone—Back pain—Lovastatin—atherosclerosis	0.0018	0.0155	CcSEcCtD
Beclomethasone—Pharyngitis—Pravastatin—atherosclerosis	0.00179	0.0154	CcSEcCtD
Beclomethasone—Infection—Rosuvastatin—atherosclerosis	0.00178	0.0153	CcSEcCtD
Beclomethasone—Back pain—Ezetimibe—atherosclerosis	0.00177	0.0152	CcSEcCtD
Beclomethasone—Angioedema—Lovastatin—atherosclerosis	0.0017	0.0146	CcSEcCtD
Beclomethasone—Angioedema—Ezetimibe—atherosclerosis	0.00167	0.0144	CcSEcCtD
Beclomethasone—Cough—Ezetimibe—atherosclerosis	0.00159	0.0137	CcSEcCtD
Beclomethasone—Angioedema—Simvastatin—atherosclerosis	0.00159	0.0137	CcSEcCtD
Beclomethasone—Pain—Rosuvastatin—atherosclerosis	0.00153	0.0132	CcSEcCtD
Beclomethasone—Dexamethasone—PLA2G1B—atherosclerosis	0.00152	0.264	CrCbGaD
Beclomethasone—Anaphylactic shock—Lovastatin—atherosclerosis	0.00152	0.0131	CcSEcCtD
Beclomethasone—Infection—Lovastatin—atherosclerosis	0.00151	0.013	CcSEcCtD
Beclomethasone—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00149	0.0128	CcSEcCtD
Beclomethasone—Infection—Ezetimibe—atherosclerosis	0.00148	0.0127	CcSEcCtD
Beclomethasone—Angioedema—Niacin—atherosclerosis	0.00146	0.0126	CcSEcCtD
Beclomethasone—Angioedema—Pravastatin—atherosclerosis	0.00144	0.0124	CcSEcCtD
Beclomethasone—Urticaria—Rosuvastatin—atherosclerosis	0.00142	0.0123	CcSEcCtD
Beclomethasone—Anaphylactic shock—Simvastatin—atherosclerosis	0.00142	0.0122	CcSEcCtD
Beclomethasone—Infection—Simvastatin—atherosclerosis	0.00141	0.0122	CcSEcCtD
Beclomethasone—Cough—Niacin—atherosclerosis	0.00139	0.012	CcSEcCtD
Beclomethasone—Cough—Pravastatin—atherosclerosis	0.00137	0.0118	CcSEcCtD
Beclomethasone—Anaphylactic shock—Niacin—atherosclerosis	0.0013	0.0112	CcSEcCtD
Beclomethasone—Pain—Lovastatin—atherosclerosis	0.0013	0.0112	CcSEcCtD
Beclomethasone—Anaphylactic shock—Pravastatin—atherosclerosis	0.00128	0.0111	CcSEcCtD
Beclomethasone—Infection—Pravastatin—atherosclerosis	0.00128	0.011	CcSEcCtD
Beclomethasone—Pain—Ezetimibe—atherosclerosis	0.00127	0.011	CcSEcCtD
Beclomethasone—Pain—Simvastatin—atherosclerosis	0.00121	0.0105	CcSEcCtD
Beclomethasone—Urticaria—Lovastatin—atherosclerosis	0.00121	0.0104	CcSEcCtD
Beclomethasone—Dizziness—Rosuvastatin—atherosclerosis	0.00118	0.0102	CcSEcCtD
Beclomethasone—Urticaria—Ezetimibe—atherosclerosis	0.00118	0.0102	CcSEcCtD
Beclomethasone—Rash—Rosuvastatin—atherosclerosis	0.00113	0.00973	CcSEcCtD
Beclomethasone—Dermatitis—Rosuvastatin—atherosclerosis	0.00113	0.00972	CcSEcCtD
Beclomethasone—Urticaria—Simvastatin—atherosclerosis	0.00113	0.00972	CcSEcCtD
Beclomethasone—Headache—Rosuvastatin—atherosclerosis	0.00112	0.00967	CcSEcCtD
Beclomethasone—Pain—Niacin—atherosclerosis	0.00112	0.0096	CcSEcCtD
Beclomethasone—Pain—Pravastatin—atherosclerosis	0.0011	0.00946	CcSEcCtD
Beclomethasone—Nausea—Rosuvastatin—atherosclerosis	0.00106	0.00916	CcSEcCtD
Beclomethasone—Urticaria—Niacin—atherosclerosis	0.00104	0.00892	CcSEcCtD
Beclomethasone—Urticaria—Pravastatin—atherosclerosis	0.00102	0.00878	CcSEcCtD
Beclomethasone—Dizziness—Lovastatin—atherosclerosis	0.001	0.00865	CcSEcCtD
Beclomethasone—Dizziness—Ezetimibe—atherosclerosis	0.000985	0.00848	CcSEcCtD
Beclomethasone—Rash—Lovastatin—atherosclerosis	0.000957	0.00824	CcSEcCtD
Beclomethasone—Dermatitis—Lovastatin—atherosclerosis	0.000957	0.00824	CcSEcCtD
Beclomethasone—Headache—Lovastatin—atherosclerosis	0.000951	0.00819	CcSEcCtD
Beclomethasone—Dizziness—Simvastatin—atherosclerosis	0.000939	0.00809	CcSEcCtD
Beclomethasone—Rash—Ezetimibe—atherosclerosis	0.000939	0.00809	CcSEcCtD
Beclomethasone—Dermatitis—Ezetimibe—atherosclerosis	0.000938	0.00808	CcSEcCtD
Beclomethasone—Headache—Ezetimibe—atherosclerosis	0.000933	0.00803	CcSEcCtD
Beclomethasone—Nausea—Lovastatin—atherosclerosis	0.000902	0.00777	CcSEcCtD
Beclomethasone—Rash—Simvastatin—atherosclerosis	0.000896	0.00771	CcSEcCtD
Beclomethasone—Dermatitis—Simvastatin—atherosclerosis	0.000895	0.0077	CcSEcCtD
Beclomethasone—Headache—Simvastatin—atherosclerosis	0.00089	0.00766	CcSEcCtD
Beclomethasone—Nausea—Ezetimibe—atherosclerosis	0.000885	0.00762	CcSEcCtD
Beclomethasone—Dizziness—Niacin—atherosclerosis	0.000862	0.00743	CcSEcCtD
Beclomethasone—Dizziness—Pravastatin—atherosclerosis	0.000849	0.00731	CcSEcCtD
Beclomethasone—Nausea—Simvastatin—atherosclerosis	0.000844	0.00726	CcSEcCtD
Beclomethasone—Rash—Niacin—atherosclerosis	0.000822	0.00708	CcSEcCtD
Beclomethasone—Dermatitis—Niacin—atherosclerosis	0.000822	0.00707	CcSEcCtD
Beclomethasone—Headache—Niacin—atherosclerosis	0.000817	0.00704	CcSEcCtD
Beclomethasone—Rash—Pravastatin—atherosclerosis	0.00081	0.00697	CcSEcCtD
Beclomethasone—Dermatitis—Pravastatin—atherosclerosis	0.000809	0.00697	CcSEcCtD
Beclomethasone—Headache—Pravastatin—atherosclerosis	0.000804	0.00693	CcSEcCtD
Beclomethasone—Nausea—Niacin—atherosclerosis	0.000775	0.00667	CcSEcCtD
Beclomethasone—Nausea—Pravastatin—atherosclerosis	0.000763	0.00657	CcSEcCtD
Beclomethasone—Dexamethasone—NOS2—atherosclerosis	0.000681	0.118	CrCbGaD
Beclomethasone—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—atherosclerosis	0.000579	0.0294	CbGpPWpGaD
Beclomethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—atherosclerosis	0.000467	0.0237	CbGpPWpGaD
Beclomethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—F7—atherosclerosis	0.000443	0.0224	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—FABP4—atherosclerosis	0.000435	0.0221	CbGpPWpGaD
Beclomethasone—Triamcinolone—PTGS2—atherosclerosis	0.00041	0.0711	CrCbGaD
Beclomethasone—NR3C1—Nuclear Receptors—ESR2—atherosclerosis	0.000366	0.0185	CbGpPWpGaD
Beclomethasone—NR3C1—Transcription factor regulation in adipogenesis—LEP—atherosclerosis	0.00036	0.0182	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—RETN—atherosclerosis	0.000357	0.0181	CbGpPWpGaD
Beclomethasone—NR3C1—Circadian Clock—NAMPT—atherosclerosis	0.00034	0.0172	CbGpPWpGaD
Beclomethasone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	0.000338	0.0171	CbGpPWpGaD
Beclomethasone—Betamethasone—PTGS2—atherosclerosis	0.000336	0.0582	CrCbGaD
Beclomethasone—CYP3A5—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	0.000333	0.0169	CbGpPWpGaD
Beclomethasone—NR3C1—Circadian Clock—F7—atherosclerosis	0.000322	0.0163	CbGpPWpGaD
Beclomethasone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—atherosclerosis	0.000313	0.0159	CbGpPWpGaD
Beclomethasone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	0.000312	0.0158	CbGpPWpGaD
Beclomethasone—CYP3A5—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	0.000308	0.0156	CbGpPWpGaD
Beclomethasone—NR3C1—Nuclear Receptor transcription pathway—ESR2—atherosclerosis	0.000289	0.0147	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—SELE—atherosclerosis	0.000275	0.014	CbGpPWpGaD
Beclomethasone—CYP3A5—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	0.000274	0.0139	CbGpPWpGaD
Beclomethasone—CYP3A5—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	0.000253	0.0128	CbGpPWpGaD
Beclomethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—atherosclerosis	0.00025	0.0127	CbGpPWpGaD
Beclomethasone—NR3C1—Nuclear Receptors—PPARA—atherosclerosis	0.000245	0.0124	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of Androgen receptor activity—SIRT1—atherosclerosis	0.000226	0.0114	CbGpPWpGaD
Beclomethasone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—atherosclerosis	0.000222	0.0112	CbGpPWpGaD
Beclomethasone—NR3C1—Nuclear Receptors—ESR1—atherosclerosis	0.000222	0.0112	CbGpPWpGaD
Beclomethasone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—atherosclerosis	0.00021	0.0107	CbGpPWpGaD
Beclomethasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—atherosclerosis	0.000207	0.0105	CbGpPWpGaD
Beclomethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—atherosclerosis	0.000204	0.0104	CbGpPWpGaD
Beclomethasone—NR3C1—Nuclear Receptors—PPARG—atherosclerosis	0.000202	0.0103	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—AHR—atherosclerosis	0.000195	0.00991	CbGpPWpGaD
Beclomethasone—Dexamethasone—PTGS2—atherosclerosis	0.000195	0.0339	CrCbGaD
Beclomethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—atherosclerosis	0.000195	0.00988	CbGpPWpGaD
Beclomethasone—NR3C1—Nuclear Receptor transcription pathway—PPARA—atherosclerosis	0.000193	0.00981	CbGpPWpGaD
Beclomethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—atherosclerosis	0.000186	0.00945	CbGpPWpGaD
Beclomethasone—NR3C1—Circadian Clock—PPARA—atherosclerosis	0.000182	0.00924	CbGpPWpGaD
Beclomethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—atherosclerosis	0.000177	0.00895	CbGpPWpGaD
Beclomethasone—NR3C1—Nuclear Receptor transcription pathway—ESR1—atherosclerosis	0.000175	0.00889	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—EDN1—atherosclerosis	0.000175	0.00889	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—HSPD1—atherosclerosis	0.000174	0.00881	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—IL10—atherosclerosis	0.000173	0.00878	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—NAMPT—atherosclerosis	0.000171	0.00867	CbGpPWpGaD
Beclomethasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—atherosclerosis	0.000166	0.00844	CbGpPWpGaD
Beclomethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—atherosclerosis	0.000162	0.00821	CbGpPWpGaD
Beclomethasone—NR3C1—Nuclear Receptor transcription pathway—PPARG—atherosclerosis	0.00016	0.00811	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—atherosclerosis	0.000154	0.00782	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—MMP1—atherosclerosis	0.000147	0.00747	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—CYP7A1—atherosclerosis	0.000146	0.00738	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—AGT—atherosclerosis	0.000145	0.00738	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—CYP7A1—atherosclerosis	0.000144	0.00728	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—ADIPOQ—atherosclerosis	0.00014	0.00709	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—ESR1—atherosclerosis	0.000136	0.0069	CbGpPWpGaD
Beclomethasone—NR3C1—Circadian Clock—SERPINE1—atherosclerosis	0.000136	0.00688	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—CYP27A1—atherosclerosis	0.000135	0.00682	CbGpPWpGaD
Beclomethasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—atherosclerosis	0.000134	0.00681	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—CYP27A1—atherosclerosis	0.000133	0.00673	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—atherosclerosis	0.00013	0.00658	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—atherosclerosis	0.000121	0.00614	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—CCL2—atherosclerosis	0.00012	0.00608	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—ESR2—atherosclerosis	0.000118	0.00599	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—atherosclerosis	0.000118	0.00598	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—SOCS3—atherosclerosis	0.000116	0.0059	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of Androgen receptor activity—MAPK8—atherosclerosis	0.000104	0.00528	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—LPL—atherosclerosis	0.000104	0.00525	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—IFNG—atherosclerosis	0.000102	0.00517	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—atherosclerosis	9.95e-05	0.00505	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—CXCL8—atherosclerosis	9.47e-05	0.0048	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—PPARA—atherosclerosis	9.15e-05	0.00464	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—IL10—atherosclerosis	9.12e-05	0.00463	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	8.98e-05	0.00455	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—AGT—atherosclerosis	8.86e-05	0.0045	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—LEP—atherosclerosis	8.69e-05	0.0044	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—MMP9—atherosclerosis	8.57e-05	0.00434	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	8.35e-05	0.00423	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—PPARG—atherosclerosis	7.57e-05	0.00384	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	7.47e-05	0.00379	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—INS—atherosclerosis	7.42e-05	0.00376	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	7.34e-05	0.00372	CbGpPWpGaD
Beclomethasone—NR3C1—Endoderm Differentiation—TGFB1—atherosclerosis	7.23e-05	0.00366	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—IGF1—atherosclerosis	7.18e-05	0.00364	CbGpPWpGaD
Beclomethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—atherosclerosis	7.12e-05	0.00361	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—TGFB1—atherosclerosis	7.06e-05	0.00358	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—SERPINE1—atherosclerosis	6.82e-05	0.00346	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	6.41e-05	0.00325	CbGpPWpGaD
Beclomethasone—CYP3A5—Biological oxidations—GSTM1—atherosclerosis	6.01e-05	0.00305	CbGpPWpGaD
Beclomethasone—CYP3A5—Metapathway biotransformation—GSTM1—atherosclerosis	5.93e-05	0.003	CbGpPWpGaD
Beclomethasone—NR3C1—AP-1 transcription factor network—IL6—atherosclerosis	5.32e-05	0.0027	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—PARP1—atherosclerosis	5.27e-05	0.00267	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—ESR2—atherosclerosis	4.99e-05	0.00253	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—atherosclerosis	4.99e-05	0.00253	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—IL1B—atherosclerosis	4.79e-05	0.00243	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	4.69e-05	0.00238	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—STAT3—atherosclerosis	4.64e-05	0.00235	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—NFKB1—atherosclerosis	4.46e-05	0.00226	CbGpPWpGaD
Beclomethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—atherosclerosis	4.37e-05	0.00221	CbGpPWpGaD
Beclomethasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	4.32e-05	0.00219	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—TGFB1—atherosclerosis	4.3e-05	0.00218	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—LDLRAP1—atherosclerosis	4.26e-05	0.00216	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—atherosclerosis	4.05e-05	0.00205	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—TNF—atherosclerosis	4.02e-05	0.00204	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PLTP—atherosclerosis	4e-05	0.00203	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—TNF—atherosclerosis	3.47e-05	0.00176	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ABCG8—atherosclerosis	3.47e-05	0.00176	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—LTA4H—atherosclerosis	3.47e-05	0.00176	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—PPARA—atherosclerosis	3.34e-05	0.00169	CbGpPWpGaD
Beclomethasone—NR3C1—Adipogenesis—IL6—atherosclerosis	3.24e-05	0.00164	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—ESR1—atherosclerosis	3.03e-05	0.00154	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—HSPA1B—atherosclerosis	2.85e-05	0.00144	CbGpPWpGaD
Beclomethasone—NR3C1—SIDS Susceptibility Pathways—IL6—atherosclerosis	2.8e-05	0.00142	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—PPARG—atherosclerosis	2.76e-05	0.0014	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ABCG1—atherosclerosis	2.74e-05	0.00139	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—FABP4—atherosclerosis	2.58e-05	0.00131	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—LCAT—atherosclerosis	2.58e-05	0.00131	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—PARP1—atherosclerosis	2.54e-05	0.00129	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—APOA4—atherosclerosis	2.53e-05	0.00128	CbGpPWpGaD
Beclomethasone—NR3C1—Generic Transcription Pathway—SERPINE1—atherosclerosis	2.49e-05	0.00126	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CYP7A1—atherosclerosis	2.49e-05	0.00126	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—ESR2—atherosclerosis	2.4e-05	0.00122	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CYP27A1—atherosclerosis	2.3e-05	0.00117	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—APOA2—atherosclerosis	2.18e-05	0.00111	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ALOX15—atherosclerosis	2.18e-05	0.00111	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PLA2G2A—atherosclerosis	2.18e-05	0.00111	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ALOX5AP—atherosclerosis	2.18e-05	0.00111	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ABCG5—atherosclerosis	2.15e-05	0.00109	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—LPA—atherosclerosis	2.08e-05	0.00105	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—BGN—atherosclerosis	2.01e-05	0.00102	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—APOA5—atherosclerosis	1.99e-05	0.00101	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—SIRT1—atherosclerosis	1.94e-05	0.000982	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PLA2G1B—atherosclerosis	1.92e-05	0.000974	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ALOX5—atherosclerosis	1.85e-05	0.00094	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.66e-05	0.000843	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—LIPC—atherosclerosis	1.65e-05	0.000838	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—APOC3—atherosclerosis	1.64e-05	0.000833	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—LDLR—atherosclerosis	1.63e-05	0.000828	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—PPARA—atherosclerosis	1.61e-05	0.000816	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CETP—atherosclerosis	1.59e-05	0.000809	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.53e-05	0.000774	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—ESR1—atherosclerosis	1.46e-05	0.000739	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.44e-05	0.000731	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—PPARG—atherosclerosis	1.33e-05	0.000675	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.29e-05	0.000652	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—SERPINE1—atherosclerosis	1.2e-05	0.000608	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.1e-05	0.000559	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—APOB—atherosclerosis	1.06e-05	0.000536	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.03e-05	0.000521	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—LPL—atherosclerosis	1.01e-05	0.000511	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—GPX1—atherosclerosis	9.84e-06	0.000499	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CD36—atherosclerosis	9.58e-06	0.000486	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—MTHFR—atherosclerosis	9.08e-06	0.00046	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PPARA—atherosclerosis	8.91e-06	0.000452	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—AGT—atherosclerosis	8.63e-06	0.000438	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—APOE—atherosclerosis	8.45e-06	0.000429	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—CAV1—atherosclerosis	8.38e-06	0.000425	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—APOA1—atherosclerosis	8.36e-06	0.000424	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—MAPK3—atherosclerosis	7.8e-06	0.000395	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PIK3CG—atherosclerosis	7.63e-06	0.000387	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PPARG—atherosclerosis	7.36e-06	0.000373	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—INS—atherosclerosis	7.22e-06	0.000366	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—ALB—atherosclerosis	6.62e-06	0.000336	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—NOS3—atherosclerosis	6.33e-06	0.000321	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—PTGS2—atherosclerosis	5.79e-06	0.000294	CbGpPWpGaD
Beclomethasone—NR3C1—Gene Expression—AKT1—atherosclerosis	5.26e-06	0.000267	CbGpPWpGaD
Beclomethasone—CYP3A5—Metabolism—AKT1—atherosclerosis	2.91e-06	0.000148	CbGpPWpGaD
